Pirfenidone-Loaded Polymeric Micelles as an Effective Mechanotherapeutic to Potentiate Immunotherapy in Mouse Tumor

Fotios Mpekris1, Petri Ch Papaphilippou2, Myrofora Panagi1

  • 1Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, 1678 Nicosia, Cyprus.

ACS Nano
|December 6, 2023
PubMed

Insights

New micellar pirfenidone combined with immune checkpoint inhibitors effectively treats solid tumors by restoring the tumor microenvironment and enhancing anti-tumor immunity.

Area of Science:

  • Oncology
  • Biomaterials Science
  • Immunotherapy

Background:

  • Solid tumors often possess dense, stiff stroma, hindering treatment efficacy.
  • Immune checkpoint inhibitors (ICIs) target the PD-1/PD-L1 axis to reactivate cytotoxic T cells.
  • Mechanotherapeutics address tumor microenvironment biomechanical abnormalities like stiffness and hypo-perfusion.

Purpose of the Study:

  • To develop a micellar formulation of pirfenidone for mechanotherapy.
  • To evaluate the efficacy of pirfenidone micelles alone and in combination with ICIs against solid tumors.
  • To assess the impact of combination therapy on tumor immunity and stiffness.

Main Methods:

  • Development of pirfenidone-loaded polymeric micelles.
  • In vivo studies using mouse models of triple-negative breast tumors (4T1, E0771) and fibrosarcoma (MCA205).
  • Combination treatment with pirfenidone micelles and anti-PD-1 immune checkpoint inhibition.
  • Assessment of tumor growth, survival, immune cell infiltration (CD4+, CD8+ T cells, myeloid-derived suppressor cells), and tumor stiffness using ultrasound shear wave elastography (SWE).

Main Results:

  • Pirfenidone micelles achieved mechanotherapeutic effects at a 100-fold lower dose than free pirfenidone.
  • Combination therapy significantly delayed tumor growth, improved overall survival, and achieved complete cure in the E0771 model.
  • Treatment increased CD4+ and CD8+ T cell infiltration and reduced myeloid-derived suppressor cells, promoting an immunostimulatory environment and immunological memory.
  • SWE effectively monitored changes in tumor stiffness, indicating optimal treatment conditions.

Conclusions:

  • Micellar encapsulation is a promising strategy for delivering mechanotherapeutics.
  • Combination therapy of pirfenidone micelles and ICIs demonstrates significant anti-tumor activity and potential for inducing long-term immunity.
  • Ultrasound shear wave elastography can aid in monitoring treatment response and optimizing clinical translation of mechanotherapeutics.

Related Concept Videos